ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,631.22
0.28%
Dow Jones
40,211.72
0.53%
US Dollar vs MXN
17.7367
0.03%
Brent Oil
83.305
-1.23%
Bitcoin
63,411.64
-2.22%
Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Co Diagnostics Inc (CODX)

  7. Co Diagnostics Inc (CODX) Noticias

CODX

Co Diagnostics (CODX)

Co Diagnostics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:CODX
FechaHoraFuenteTítuloSímboloCompañía
28/04/202208:30PR Newswire (US)CO-DIAGNOSTICS, INC. ANNOUNCES FIRST QUARTER 2022 EARNINGS RELEASE DATE AND WEBCASTNASDAQ:CODXCo Diagnostics Inc
22/04/202208:30PR Newswire (US)Co-Diagnostics, Inc. to Host Booth at ECCMID 2022 in Lisbon, Portugal on April 23-26NASDAQ:CODXCo Diagnostics Inc
19/04/202208:30PR Newswire (US)Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis C Viral Load TestNASDAQ:CODXCo Diagnostics Inc
01/04/202216:02Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CODXCo Diagnostics Inc
24/03/202215:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:CODXCo Diagnostics Inc
24/03/202215:01PR Newswire (US)Co-Diagnostics Reports Full Year 2021 Financial ResultsNASDAQ:CODXCo Diagnostics Inc
22/03/202208:30PR Newswire (US)Co-Diagnostics, Inc. to Present at MarketsandMarkets Conference on March 23-24 in London, EnglandNASDAQ:CODXCo Diagnostics Inc
17/03/202208:30PR Newswire (US)Co-Diagnostics, Inc. Makes Strategic Additions to Scientific Advisory BoardNASDAQ:CODXCo Diagnostics Inc
15/03/202208:30PR Newswire (US)Co-Diagnostics, Inc. Announces Authorization of $30 Million Share Repurchase ProgramNASDAQ:CODXCo Diagnostics Inc
14/03/202208:30PR Newswire (US)CO-DIAGNOSTICS, INC. ANNOUNCES FOURTH QUARTER AND FULL YEAR 2021 EARNINGS RELEASE DATE AND WEBCASTNASDAQ:CODXCo Diagnostics Inc
17/02/202208:30PR Newswire (US)Co-Diagnostics, Inc. to Sponsor and Present at Molecular Med Tri-Con 2022NASDAQ:CODXCo Diagnostics Inc
10/02/202208:30PR Newswire (US)Co-Diagnostics, Inc. to Host Booth at Life Sciences Day on the Hill on February 16 at the Utah State CapitalNASDAQ:CODXCo Diagnostics Inc
03/02/202208:30PR Newswire (US)Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for Hepatitis B Viral Load TestNASDAQ:CODXCo Diagnostics Inc
21/01/202208:30PR Newswire (US)Co-Diagnostics, Inc. to Host Booth at Medlab Middle East 2022 in Dubai on January 24-27NASDAQ:CODXCo Diagnostics Inc
14/01/202215:19Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:CODXCo Diagnostics Inc
13/01/202208:30PR Newswire (US)Co-Diagnostics, Inc. JV CoSara Receives Clearance from Indian Regulators for High-Risk HPV Multiplex TestNASDAQ:CODXCo Diagnostics Inc
10/01/202216:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CODXCo Diagnostics Inc
10/01/202205:30PR Newswire (US)Co-Diagnostics, Inc. to Participate in the H.C. Wainwright 2022 BioConnect Virtual Conference on January 10-13NASDAQ:CODXCo Diagnostics Inc
31/12/202108:30PR Newswire (US)Co-Diagnostics, Inc. Announces Completion of the Acquisition of all Assets and Intellectual Property Related to At-Home/Point-of-Care PlatformNASDAQ:CODXCo Diagnostics Inc
23/12/202105:25TipRanksH.C. Wainwright Keeps a Buy Rating on Co-Diagnostics (CODX)NASDAQ:CODXCo Diagnostics Inc
22/12/202108:25PR Newswire (US)Co-Diagnostics, Inc. Signs Agreement to Acquire all Assets and Intellectual Property Related to At-Home/Point-of-Care PlatformNASDAQ:CODXCo Diagnostics Inc
08/12/202105:19TipRanksH.C. Wainwright Thinks Co-Diagnostics’ Stock is Going to RecoverNASDAQ:CODXCo Diagnostics Inc
07/12/202115:00PR Newswire (US)Creator of COVID-19 and Global Molecular Testing Products Co-Diagnostics, Inc. Launches Retail Investor and Perks Program with TiiCKERNASDAQ:CODXCo Diagnostics Inc
07/12/202108:25PR Newswire (US)Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for ABC Multiplex TestNASDAQ:CODXCo Diagnostics Inc
30/11/202105:18TipRanksCo-Diagnostics (CODX) Receives a Buy from H.C. WainwrightNASDAQ:CODXCo Diagnostics Inc
29/11/202107:00PR Newswire (US)Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron VariantNASDAQ:CODXCo Diagnostics Inc
15/11/202110:30PR Newswire (US)Co-Diagnostics, Inc. to Host Booth at MEDICA 2021 Trade Fair in Düsseldorf, GermanyNASDAQ:CODXCo Diagnostics Inc
12/11/202105:13Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CODXCo Diagnostics Inc
11/11/202115:01PR Newswire (US)Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial ResultsNASDAQ:CODXCo Diagnostics Inc
04/11/202108:38PR Newswire (US)Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United KingdomNASDAQ:CODXCo Diagnostics Inc
 Showing the most relevant articles for your search:NASDAQ:CODX

Su Consulta Reciente

NYSE
KO
Coca Cola
AMEX
SPY
SPDR S&P 500
NASDAQ
NVDA
NVIDIA
PM
XAUUSD
Gold vs US Dollar
USOTC
RHHBY
Roche (QX)
NYSE
DIS
Walt Disney
USOTC
BASFY
BASF (QX)
CCOM
US30
US 30
NYSE
CVX
Chevron
NASDAQ
TSLA
Tesla
FX
EURUSD
Euro vs US Dollar
NYSE
JPM
JP Morgan Chase
COIN
SOLUSD
Solana
AMEX
XLV
Health Care Select Sector
NYSE
BAC
Bank of America
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados